Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-Related Hypercalcemia.

Anne-Lise Lecoq1, Marine Livrozet2, Anne Blanchard2

  • 1Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares du Métabolisme du Calcium et du Phosphate, Filière OSCAR, 78 rue du Général Leclerc, Le Kremlin Bicêtre 94270, France.

Endocrinology and Metabolism Clinics of North America
|November 14, 2021
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The renin-angiotensin system is activated by short-term, but repressed by long-term growth hormone excess.

European journal of endocrinology·2026
Same author

Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment.

European journal of endocrinology·2026
Same author

Health-related quality of life in French adults with X-linked hypophosphatemia: real-world data from the International XLH Registry.

JBMR plus·2026
Same author

Risk of bone overstimulation in long-term PTH(1-34) therapy for hypoparathyroidism.

European journal of endocrinology·2026
Same author

NK cells promote cardiac cell death and regulate myelopoiesis in myocardial infarction.

Nature communications·2026
Same author

KDM1A pathogenic variants link epigenetic regulation to GIP-dependent primary bilateral macronodular adrenal hyperplasia.

Annales d'endocrinologie·2026
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles
This summary is machine-generated.

Certain medications, including Vitamin D, thiazides, and lithium, can cause hypercalcemia. This review details their mechanisms and management strategies for drug-induced hypercalcemia.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Nephrology

Background:

  • Hypercalcemia is a common electrolyte disturbance.
  • Medications are a frequent cause of iatrogenic hypercalcemia.
  • Understanding drug-induced hypercalcemia is crucial for patient management.

Purpose of the Study:

  • To review commonly prescribed medications causing hypercalcemia.
  • To elucidate the pathophysiological mechanisms of drug-induced hypercalcemia.
  • To outline optimal medical management strategies for these conditions.

Main Methods:

  • Literature review of studies on drug-induced hypercalcemia.
  • Analysis of pharmacological mechanisms of calcium dysregulation.
  • Synthesis of clinical data on prevalence and management.
Keywords:
DenosumabIatrogenic hypercalcemiaLithiumRecombinant human PTHTamoxifenThiazide diureticsVitamin D analoguesVitamin a analogues

Related Experiment Videos

Main Results:

  • Vitamin D and its analogues enhance calcium absorption and bone resorption.
  • Recombinant human parathyroid hormone (PTH) can cause transient hypercalcemia in hypoparathyroidism.
  • Thiazides increase renal calcium reabsorption, and lithium can induce hyperparathyroidism.

Conclusions:

  • Several common medications can precipitate hypercalcemia through distinct mechanisms.
  • Accurate diagnosis and understanding of drug effects are key to managing hypercalcemia.
  • Tailored medical management is essential for addressing drug-induced hypercalcemia.